Overview
Cilcare is a French-US based biotechnology company specializing in auditory sciences, dedicated to developing cutting-edge solutions for the characterization, diagnosis, and treatment of hearing disorders and related diseases. Since its inception in 2014, Cilcare has been tackling global hearing health challenges by combining an advanced R&D platform, a promising pipeline of drug candidates, and the power of AI to better characterize different forms of hearing loss, ultimately aiming to revolutionize the medicine of tomorrow.
Company News
CILcare announces appointment of Alain Chatelin, acting as Chief Medical Officer
Jul 17, 2023
Posted by CILcare
